secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syndax Pharmaceuticals Inc (SNDX)
CIK:        0001395937
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0000950170-23-002172
Event type: other
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syndax adopts 2023 Inducement Plan, reserving 1.9M shares for new-hire equity grants
--------------------------------------------------------------------------------

- Board approved 2023 Inducement Plan on Feb 2, 2023, under Nasdaq Rule 5635(c)(4) for inducement grants.
- Plan reserves 1.9M shares of common stock for issuance to new employees as material inducement to employment.
- Plan is substantially similar to 2015 Omnibus Incentive Plan but prohibits incentive stock options.
- Grants require approval by a majority of Independent Directors or Independent Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1395937/000095017023002172/0000950170-23-002172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1395937/000095017023002172/sndx-20230202.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer